eMedicals Healthtech GmbH is an innovative and ambitious
start-up in the Digital Health sector, based in Frankfurt am
Main. The German Federal Ministry of Education and Research and
the Fraunhofer Society awarded us as one of the most innovative
Health-Tech companies in Germany.
We develop a holistic concept with patient-centered solutions for all stakeholders in the Chronic Kidney Disease (CKD) ecosystem. These include patients, physicians, hospitals, dialysis centers, dieticians, research institutes, universities, pharmaceutical companies, health insurers, and governmental institutions. We are deeply convinced that an excellent therapy for CKD patients requires coordination and interaction among these stakeholders.
Our mission is to develop an intelligent nutritional assistant that empowers patients suffering from Chronic Kidney Disease (CKD) to manage the complexity of their disease and supports physicians with their therapy decisions.
In the future, our digital healthcare platform coordinates the interactions of all stakeholders in a disease`s ecosystem and hereby empowers every patient to pro-actively shape his or her own health.
Our first step towards our mission is to enable patients to take a well-informed, active role in their nutritional decision process and blood pressure management. We make this possible through our Digital Nutritional Assistant: kidiDNA.
kidiDNA is a medical application that expands and complements
the services of a medical nutrition expert and makes them
digitally accessible to a wide audience.
It allows for the “kidiDNA therapy”, which is a personalized and precise, real-time nutrition therapy based on continuously collected health data from the patient.
The nutrition therapy aims to slow down the patients’ shift into higher CKD stages by regulating their micronutrient intake to improve the functioning of the kidney, and by monitoring their sugar, salt, and alcohol intake, among other inputs, to regulate their blood pressure to directly relieve the kidney.
In addition to the improved quality of life of our users, our technology leads, in the long-term, to a reduction in the consumption of pharmaceuticals (e.g. phosphate binders, potassium blockers).
Our technology also supports daily clinical activities of physicians and increases the efficiency and quality of their medical decisions.
We increase the quality of life of patients thanks to real-time nutrition therapy, enabling them to make well-informed nutrition-related decisions.
We facilitate the everyday work life of physicians through more efficient communication, by providing them with visual tools for decision making, and by reducing the frequency of required doctor visits.
We enable health insurers to save costs thanks to a decrease in required pharmaceutical consumption, hospital stays and dialysis usage of patients.
We provide new insights to research institutions, leading to innovative treatment methods and increasing the validity of studies through the availability of data from real-life settings.
We achieve a reduction of personal and financial resource wastage for hospitals, for example by avoiding unnecessary double-examinations.
Achievements (so far)
Proof of Concept by AOK Nordost
AOK Nordost recognized our therapy concept for the specific needs and nutritional requirements of patients with kidney disease as very innovative. According to the renowned health insurance company, there is currently no equivalent digital offering to kidiDNA in Germany.
Winner of InnoHealth China 2020
eMedicals Healthtech GmbH is one of the winners of “InnoHealthChina 2020”, a joint campaign by the Fraunhofer Society and the German Federal Ministry of Education and Research. Our project “Kidi - digital integrated care supply platform for patients with kidney disease”, in collaboration with the University Hospital Frankfurt am Main, was awarded for its innovative concept. Within the framework of the initiative “Research in Germany”, our start-up now represents Germany as a research location abroad. With this award, we will be able to take part in “Matching Tour China“ organized by the German Chamber of Commerce in Beijing, China, which will take place in the Fall of 2020. This will give us the opportunity to meet with Chinese research institutions, companies and investors.
Following an invitation by the Marburg Institute for Innovation Research and Business Start-Up Support (MAFEX), we took part in “Futura 2019”, a start-up competition organized by Gerina AG. Here we placed second out of nine teams and were considered the most innovative idea in the Digital Health field. It was at this event that we were first approached by major institutional investors.
Accepted in the “ChancenNutzer” program by JP Morgan Chase Foundation
The Social Impact Lab incubator in Frankfurt, assessed our idea as an innovation of great social impact. We inspired our judges with our future-shaping concept and were granted a place at the ChancenNutzer program, funded by the JP Morgan Chase Foundation. We were hereby given access to co-working spaces, professional business coaching, consulting services, legal advice and networking opportunities.